Improvements to product and distribution aimed at satisfying growing customer demand
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
D&D Medical, Inc.
Brain Scientific signs distribution partnership with D&D Medical, Inc. NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
Brain Scientific
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
LAKEWOOD RANCH, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific (OTCQB:BRSF), a Florida-based medical device technology company, announces today the immediate release of the improved and updated NeuroCap™ device and the signing of a distribution partnership with D&D Medical, Inc., to sell the company's neurology devices in Tennessee, Kentucky, Indiana, and West Virginia.
D&D Medical, Inc., brings innovative medical technologies to market by educating medical professionals in their use and distributing them to where they are needed most.
"The NeuroCap makes EEG testing more comfortable for patients and efficient for clinicians," said Don Sizemore, President of D&D Medical, Inc. "When I was introduced to the NeuroCap, and tested it in the field, I knew that it would make a big difference in the lives of patients needing neurological testing and the clinical staff carrying out their EEG exams."
NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
Brain Scientific's newly improved NeuroCap recently entered production for the company and its distributors to build stock and fulfill customer requests. The improvements to the NeuroCap include a proprietary gel with better conductivity, improved performance adhesive pads, a more conductive, precise ink formulation, and a base of modern blue PET material.
"Our improved NeuroCap is a more comfortable, easy-to-use, and efficient way to conduct EEG exams," said Hassan Kotob, chairman and CEO of Brain Scientific. "The disposable NeuroCap, which is available for immediate shipping, allows clinicians to save prep time and see more patients, accelerating the timeline to results for critical EEG exams."
Brain Scientific developed the NeuroCap to streamline EEG prep, testing and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system.
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes. The NeuroCap can be used in nearly any environment, including rural hospitals, ambulances, private practices and athletic events, vastly expanding access to EEG testing. It is currently available in four sizes, including pediatric sizes.
About Brain Scientific
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap™ and NeuroEEG™ are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
CONTACTS
INVESTORS
ir@brainscientific.com
MEDIA
pr@brainscientific.com
Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
Attachments
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- D&D Medical, Inc.
- Brain Scientific
Improvements to product and distribution aimed at satisfying growing customer demand
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
Brain Science NeuroCap是一款FDA 510k透明、預凝膠的臨牀使用的一次性EEG耳機。它允許任何臨牀醫生在正常情況下使用單個電極的一小部分時間就可以為患者的腦電檢查做好準備。
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
Brain Science NeuroCap是一款FDA 510k透明、預凝膠的臨牀使用的一次性EEG耳機。它允許任何臨牀醫生在正常情況下使用單個電極的一小部分時間就可以為患者的腦電檢查做好準備。
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
Brain Science NeuroCap是一款FDA 510k透明、預凝膠的臨牀使用的一次性EEG耳機。它允許任何臨牀醫生在正常情況下使用單個電極的一小部分時間就可以為患者的腦電檢查做好準備。
The Brain Scientific NeuroCap
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes.
Brain Science NeuroCap是一款FDA 510k透明、預凝膠的臨牀使用的一次性EEG耳機。它允許任何臨牀醫生在正常情況下使用單個電極的一小部分時間就可以為患者的腦電檢查做好準備。
Brain Scientific signs distribution partnership with D&D Medical, Inc. NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
與D&D醫療公司的腦科學標誌分銷合作伙伴關係NeuroCap滿足了D&D醫療公司用來選擇新技術代表的三個標準：它為患者和臨牀醫生提供了更安全的替代方案，它是創新的和新的，它節省了醫院和患者的資金。
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
Brain Science是一家擁有多項專利和FDA批准產品的醫療技術公司。Brain Science致力於開發下一代解決方案，以推動神經診斷和OEM醫療設備的未來。NeuroCap符合D&D Medical選擇新技術代表的三個標準：它為患者和臨牀醫生提供了更安全的替代方案，它是創新的和新的，它為醫院和患者節省了資金。
LAKEWOOD RANCH, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific (OTCQB:BRSF), a Florida-based medical device technology company, announces today the immediate release of the improved and updated NeuroCap™ device and the signing of a distribution partnership with D&D Medical, Inc., to sell the company's neurology devices in Tennessee, Kentucky, Indiana, and West Virginia.
佛羅裏達州萊克伍德牧場，2022年11月15日(Global Newswire)--來自InvestorWire -- 總部位於佛羅裏達州的醫療設備技術公司Brain Science(場外交易市場代碼：BRSF)今天宣佈，將立即發佈改進和更新的™設備，並與D&D醫療公司簽署分銷合作伙伴關係，在田納西州、肯塔基州、印第安納州和西弗吉尼亞州銷售該公司的神經學設備。
D&D Medical, Inc., brings innovative medical technologies to market by educating medical professionals in their use and distributing them to where they are needed most.
D&D醫療公司通過教育醫療專業人員使用創新的醫療技術並將其分發到最需要的地方，將創新的醫療技術推向市場。
"The NeuroCap makes EEG testing more comfortable for patients and efficient for clinicians," said Don Sizemore, President of D&D Medical, Inc. "When I was introduced to the NeuroCap, and tested it in the field, I knew that it would make a big difference in the lives of patients needing neurological testing and the clinical staff carrying out their EEG exams."
D&D醫療公司的唐·西澤莫爾説：“NeuroCap使患者的腦電測試更加舒適，臨牀醫生也更加高效。”當我被介紹給NeuroCap，並在現場進行測試時，我知道它將對需要神經學測試的患者和進行腦電檢查的臨牀工作人員的生活產生重大影響。
NeuroCap satisfies the three criteria D&D Medical uses to select new technologies to represent: it provides a safer alternative for the patients and clinicians, it's innovative and new, and it saves hospitals and patients money.
NeuroCap符合D&D Medical選擇新技術代表的三個標準：它為患者和臨牀醫生提供了更安全的替代方案，它是創新的和新的，它為醫院和患者節省了資金。
Brain Scientific's newly improved NeuroCap recently entered production for the company and its distributors to build stock and fulfill customer requests. The improvements to the NeuroCap include a proprietary gel with better conductivity, improved performance adhesive pads, a more conductive, precise ink formulation, and a base of modern blue PET material.
Brain Science新改進的NeuroCap最近為該公司及其分銷商投入生產，以積累庫存並滿足客户的要求。對NeuroCap的改進包括具有更好導電性的專有凝膠、性能更好的粘合墊、更導電、更精確的墨水配方以及現代藍色PET材料的基礎。
"Our improved NeuroCap is a more comfortable, easy-to-use, and efficient way to conduct EEG exams," said Hassan Kotob, chairman and CEO of Brain Scientific. "The disposable NeuroCap, which is available for immediate shipping, allows clinicians to save prep time and see more patients, accelerating the timeline to results for critical EEG exams."
Brain Science董事長兼首席執行官哈桑·科託布表示：“我們改進後的NeuroCap是一種更舒適、更易用、更高效的腦電檢查方法。”一次性的NeuroCap可以立即發貨，使臨牀醫生可以節省準備時間，看更多的患者，加快關鍵腦電檢查結果的時間線。“
Brain Scientific developed the NeuroCap to streamline EEG prep, testing and diagnosis. NeuroCap has 22 pre-gelled electrodes making it a suitable option for most clinical EEG tests, including routine EEGs that are often used for stroke and epilepsy patients. The fixed electrode placement is in accordance with the international 10-20 system.
Brain Science開發了NeuroCap，以簡化腦電準備、測試和診斷。NeuroCap有22個預凝膠電極，這使其成為大多數臨牀腦電測試的合適選擇，包括經常用於中風和癲癇患者的常規腦電檢查。固定電極位置按照國際10-20系統。
The Brain Scientific NeuroCap is an FDA 510k cleared, pre-gelled disposable EEG headset for clinical use. It allows any clinician to prepare a patient for an EEG exam in a fraction of the time normally spent applying individual electrodes. The NeuroCap can be used in nearly any environment, including rural hospitals, ambulances, private practices and athletic events, vastly expanding access to EEG testing. It is currently available in four sizes, including pediatric sizes.
Brain Science NeuroCap是一款FDA 510k透明、預凝膠的臨牀使用的一次性EEG耳機。它允許任何臨牀醫生在正常情況下使用單個電極的一小部分時間就可以為患者的腦電檢查做好準備。NeuroCap幾乎可以在任何環境中使用，包括鄉村醫院、救護車、私人診所和體育賽事，極大地擴大了腦電測試的範圍。它目前有四種尺寸可供選擇，包括兒科尺寸。
Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap™ and NeuroEEG™ are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.
Brain Science是一家擁有多項專利和FDA批准產品的醫療技術公司。Brain Science致力於開發下一代解決方案，以推動神經診斷和OEM醫療設備的未來。Brain Science有兩個產品線，涵蓋神經學和精密運動。NeuroCap™和NeuroEEG™是智能神經診斷設備，可簡化管理、縮短掃描時間並降低成本。Piezo Motion產品線由超高效緊湊型精密電機組成，將驅動下一代醫療設備。欲瞭解有關Brain Science公司的公司戰略、產品或投資者關係的更多信息，請訪問BrainScience網站。
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.
本新聞稿中包含的任何不描述歷史事實的陳述都可能構成前瞻性陳述。前瞻性陳述可能包括但不限於以下陳述：(I)未來業務的管理計劃和目標，包括與腦電產品和服務以及壓電電機技術的設計、開發和商業化有關的計劃或目標；(Ii)收入(包括收入/虧損)、每股收益(包括收益/虧損)、資本支出、股息、資本結構或其他財務項目的預測；(Iii)公司未來的財務表現；(Iv)Piezo Motion與Brain Science的成功整合；以及(V)以上第(I)、(Ii)、(Iii)或(Iv)點所述任何陳述所依據的或與之有關的假設。此類前瞻性陳述不是為了預測或保證實際結果、業績、事件或情況，也可能無法實現，因為它們是基於公司目前的預測、計劃、目標、信念、預期、估計和假設，受許多風險、不確定性和其他影響的影響，其中許多是公司無法控制的。由於這些風險和不確定性，某些事件和情況的實際結果和時間可能與前瞻性陳述中描述的大不相同。可能影響或導致前瞻性陳述不準確或導致實際結果與預期或期望結果大不相同的因素可能包括但不限於, 該公司無法獲得更多融資；與開發產品和相關產品相關的時間和資源過長；現金流不足和由此導致的流動性不足；該公司無法擴大其業務；政府對醫療器械和醫療保健行業的監管力度較大；缺乏產品多元化；該公司原材料價格波動；以及未能實施該公司的業務計劃或戰略。在該公司提交給美國證券交易委員會的文件中，對其中一些因素以及其他一些因素進行了識別和更詳細的描述。該公司不承諾更新這些前瞻性陳述。
INVESTORS
ir@brainscientific.com
投資商
郵箱：ir@brainScience fic.com
MEDIA
pr@brainscientific.com
媒體
電子郵箱：pr@brainScience fic.com
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
IBN(InvestorBrandNetwork)
加利福尼亞州洛杉磯
310.299.1717辦公室
郵箱：EDITOR@InvestorBrandNetwork.com
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- The Brain Scientific NeuroCap
- D&D Medical, Inc.
- Brain Scientific
- 腦科學NeuroCap
- 腦科學NeuroCap
- 腦科學NeuroCap
- 腦科學NeuroCap
- D&D醫療公司
- 腦科學
